Study Stopped
lack of funding
Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?
A Randomized Controlled Trial Showing the Effect of Patient Lenght of Stay in the Emergency Department Through Utilizing a Urinalysis Nursing Protocol.
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The implementation of nursing urinanlysis protocols based off of symptoms of urinary infections will significantly decrease the length of a patient's stay in the Emergency Department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2007
CompletedFirst Posted
Study publicly available on registry
December 31, 2007
CompletedStudy Start
First participant enrolled
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedMay 13, 2016
May 1, 2016
December 20, 2007
May 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of Stay in the Emergency Department
1 hour
Secondary Outcomes (1)
Physician decision making on ordering urinalysis based off of chief complaints
1 hour
Study Arms (2)
1
EXPERIMENTALRecieves urinalysis by nurse per set protocol based off of inclusion criteria
2
NO INTERVENTIONordering of test will be up to the treating physician
Interventions
Eligibility Criteria
You may qualify if:
- patients between 16 and 65 years of age complaining of any of the following: dysuria, hematuria, urinary frequency, urinary urgency
You may not qualify if:
- any person less than 16 or greater than 65 years of age, history of kidney disease or transplant, foley catherization within the last 30 days, on immuno-suppresent and/or receiving chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Los Angeles Medical Center
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew W Seefeld, M.D.
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 20, 2007
First Posted
December 31, 2007
Study Start
February 1, 2008
Study Completion
February 1, 2009
Last Updated
May 13, 2016
Record last verified: 2016-05